Fact CheckerSign in

NCT06786260Not yet recruiting

Di-PKD: A Pilot Trial of Dietary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease

Di-PKD: A Pilot Trial of a 12-Month Targeted Dietary Intervention on Cyst Progression in Patients With Autosomal Dominant Polycystic Kidney Disease

Source: ClinicalTrials.gov · Last updated 30 Jan 2026

Brief summary (registry, in English)

The goal of this interventional study is to evaluate the impact of a specific diet (low salt, limited caffeine, high potassium, low phosphate, limited protein, limited carbohydrate intake, adequate water intake) on changes in serum and urinary biomarkers, total kidney volume (TKV), and cyst progression in subjects with autosomal dominant polycystic kidney disease (ADPKD). Researchers will compare the results of subjects in the study diet (interventional) arm to the results of subjects in the regular diet (control) arm.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
10 Jan 2025
Start date
May 2026
Primary completion date
Dec 2026
Lead sponsor
Loma Linda University
NCT number
NCT06786260

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From May 2026 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of dietary non-adherence
  • Comorbidities that could interfere with participation (Diabetes, Heart Failure (EF\<30%) Advanced Chronic Kidney Disease (CKD) Stage 4 and higher)

Other

  • Subjects on Tolvaptan

Who the study is looking for

  • Confirmed diagnosis of ADPKD
  • Genetic testing confirmation of PKD1 or PKD2
  • eGFR \>30mL/1.73m2
  • Willingness to adhere to a preconditioning diet for 1 week and ability to complete the study
  • Mayo Clinic Imaging Classification (MCIC): 1C, 1D, 1E

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Loma Linda University Health
Coordinator of this site? Confirm its status
Loma LindaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.